Efficacy and safety of sorafenib for advanced renal cell carcinoma: real-world data of patients with renal impairment.

about

Efficacy and safety of sorafenib for advanced renal cell carcinoma: real-world data of patients with renal impairment.

Item

http://www.wikidata.org/entity/Q52714334

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Efficacy and safety of sorafen ...... atients with renal impairment.

@en

Efficacy and safety of sorafen ...... atients with renal impairment.

@nl

type

Item

label

Efficacy and safety of sorafen ...... atients with renal impairment.

@en

Efficacy and safety of sorafen ...... atients with renal impairment.

@nl

prefLabel

Efficacy and safety of sorafen ...... atients with renal impairment.

@en

Efficacy and safety of sorafen ...... atients with renal impairment.

@nl

P1476

Efficacy and safety of sorafen ...... atients with renal impairment.

@en

P2093

Hideyuki Akaza

http://www.w3.org/2001/XMLSchema#string

Katsunori Tatsugami

http://www.w3.org/2001/XMLSchema#string

Koki Kabu

http://www.w3.org/2001/XMLSchema#string

Mototsugu Oya

http://www.w3.org/2001/XMLSchema#string

P2860

VEGF inhibition and renal thrombotic microangiopathy

Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

Sorafenib in advanced clear-cell renal-cell carcinoma

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial.

Increased risk of everolimus-associated acute kidney injury in cancer patients with impaired kidney function.

A large-scale prospective registration study of the safety and efficacy of sorafenib tosylate in unresectable or metastatic renal cell carcinoma in Japan: results of over 3200 consecutive cases in post-marketing all-patient surveillance.

Sorafenib.

Chronic kidney disease after nephrectomy in patients with renal cortical tumours: a retrospective cohort study.

P304

19406-19414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24779

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29721212

http://www.w3.org/2001/XMLSchema#string

P932

5922406

http://www.w3.org/2001/XMLSchema#string